<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) --> <script async src="https://www.googletagmanager.com/gtag/js?id=G-KKS2Y8FR6L"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-KKS2Y8FR6L'); </script>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../figures/favicon.png" type="image/x-icon">
  <title>Control of Conception (Family Planning)</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="/style.css">
  <link rel="stylesheet" href="/notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="/index.html">
    <div class="home-navigation">
      M
    </div>
  </a>

  <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="/index.html">Home</a>
      </li>
      <li class="menu__item">
        <a class="menu__link" href="/about-temp2.html">About</a>
      </li>
      
     
      

      <!-- <li class="menu__item">
        <a class="menu__link" href="#0">Projects</a>
        <ul class="submenu">
          <li class="menu__item">
            <a class="menu__link" href="/404.html">Surgery</a>
          </li>
          <li class="menu__item">
            <a class="menu__link" href="/404.html">Pediatrics</a>
          </li>
        </ul>
      </li> -->
    </ul>
  </nav>
  
  <main class="page-container">
    <!-- <div class="contribute-cta">
      <p>Help make this better💜</p>
      <span><a href="/contribute.html">Contribute here</a> </span>
    </div> -->

    <h1>Control of Conception (Family Planning)</h1>
  
    <!-- <div class="author-flex">
      <div class="author-img">
        <img  src="/contributors/vt1.jpeg" alt="">
      </div>
      <div>
        <h2 class="name">Compiled by Victortayo</h2>
        <p class="updated">last updated, Nov 2022</p>
      </div>
    </div> -->

    <article class="notes">
        <a id='top'></a>
    <article>
    <!-- <h2 class='title'>Outline</h2> -->
    <label class="trigger outline">
        <input type="checkbox" class="checkbox checkbox--red" /> Show/hide outline
        <div class="msg">
         <ol>
            <li><a href="#header-1">Introduction</a></li>
            <li><a href="#header-2">Modern Methods of Contraception</a></li>
            <li><a href="#header-3">Constraints for Contraceptive Development</a></li>
         </ol>
        </div>
      </label>

      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
          <p>There are about 1.2 billion women of reproductive age world wide</p>
          <p>About 114 - 120 million acts of sexual intercourse each day worldwide</p>
          <p>Likely to result in 910,000 conceptions</p>
          <p>A significant number of these conceptions / pregnancies are unwanted</p>
          <p>Contraception a key strategy for the prevention of unwanted pregnancy</p>
          <p>Like all aspects of medicine, contraception is also witnessing advances, changes, improvements, etc</p>
          <p>A single human ejaculate has the potential to equal population of USA and Canada</p>
          <ul>
            <li>4ml x 90 million = 360 million (355 million)</li>
          </ul>
          <p>A healthy man in his lifetime produces enough sperm to replace the whole human race</p>
          <ul>
            <li>7.2 billion as of 2014</li>
          </ul>

          <section id='heading-1-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-1-1'>Historical perspective</a>
              </h3>
            </header>
            <div class='body'>
               <p>Age long practice, different people across generations have devised different means of controlling conception</p>
               <p>1850 BCE-kahum papyrus- pessary from crocodile dung and fermented dough- this created a hostile environment for sperm.</p>
               <p>The Kahun papyrus also refers to vaginal plugs of gum, honey, and acacia.</p>
               <p>Early second century in Rome, Soranus of Ephesus-acidic concoction of fruits, nuts, and wool, placed at the cervical os to create a spermicidal barrier. </p>
               <p>Voluntary control of conception is of paramount importance to modern society.</p>
               <p>Globally- rapid population growth threatens human survival.</p>
               <p>In another 40 years the world will double its population while in less than 20 years in the poorer countries.</p>
               <p> Effective control of reproduction can be essential to a woman's ability to achieve her individual goals and to contribute to her sense of well-being</p>
               <p>A patient's choice of contraceptive method involves factors such as efficacy, safety, non-contraceptive benefits, cost, and personal considerations.</p>
               <p>Decision making concerning fertility, for many is a deeply personal and sensitive issue, often involving religious or philosophical convictions.</p>
               <p>Despite the introduction of modern contraceptive methods, unintended and unplanned pregnancies continue to be a major problem worldwide.</p>
            </div>
          </section>

          <section id='heading-1-2'>
            <header>
              <h3>
                <a aria-hidden href='#heading-1-2'>Facts from DHS</a>
              </h3>
            </header>
            <div class='body'>
               <p>Current contraceptive use: modern contraceptive use is higher among the sexually active unmarried women (28%) than among currently married women (12%).</p>
               <p>Contraceptive prevalence rate for any method is 17% among the currently married women</p>
               <p>Contraceptive discontinuation: 2 of every 5x (41%) that women began using contraceptive method in 5 years preceding the survey. They discontinue within 12 months. The most common reason was desire to become pregnant (35%)</p>
               <p>Demand for family planning: among currently married women is 36%. </p>
               <p>Unmet need for family planning: higher among sexually active unmarried women (48%) than among the currently married women (19%)</p>
               <p>Future use of contraception: 35% of currently married women who are not using contraception intend to use family planning in the future</p>
               <p>Unmet need for contraception refers to the percentage of fecund (do not meet the criteria for infecundity) and sexually active women (married or in a union) of reproductive age who wish to postpone the next birth for at least 2 years or halt child bearing completely but are not using any form of contraception.</p>
               <p>This concept points to the gap between women’s reproductive intentions and their contraceptive behavior.</p>
               <p>214 million women of reproductive age in developing regions have unmet need for contraception. Reasons include—</p>
               <ul>
                <li>Limited access to contraception</li>
                <li>A limited choice of methods</li>
                <li>A fear or experience of side effects</li>
                <li>Cultural or religious opposition</li>
                <li>Poor quality of available resources  </li>
                <li>Gender </li>
               </ul>

               <figure>
                <img src="/figures/coc (1).png" alt="">
                <figcaption> Fig. Contraceptive Knowledge by Zones</figcaption>
               </figure>

               <figure>
                <img src="/figures/coc (6).png" alt="">
                <figcaption>Fig. Use of Modern Contraception in Nigeria by Zones </figcaption>
               </figure>

               <figure>
                <img src="/figures/coc (8).png" alt="">
                <figcaption> Fig. Contraceptives prevalence</figcaption>
               </figure>

               <p>For all Indications, providers of Family Planning must provide accurate information about benefits and risks of:</p>
               <ul>
                <li>Pregnancy</li>
                <li>Contraception</li>
               </ul>
               <p>To be noted specifically are:</p>
               <ul>
                <li>Medical conditions that may substantially increase risk of some form of birth control usually increase the risk associated with pregnancy to an even greater extent.</li>
                <li>Policy in some less developed countries promote contraception in an effort to curb undesired population growth.</li>
               </ul>

            </div>
          </section>
        </div>

      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Modern Methods of Contraception</a>
          </h2>
        </header>
        <div class='body'>
            <ol type="A">
              <li>Coitus Interruptus or Withdrawal Method</li>
              <li>Lactational Amenorrhea Method (LAM)</li>
              <li>Natural FP Methods (Safe Period and Abstinence)</li>
              <ul>
                <li>Cervical mucus (Spinberkeit)</li>
                <li>Temperature </li>
                <li>Sympto-thermal</li>
                <li>Cycle beads (Standard Days Method)</li>
                <li>Ovulation prediction devices</li>
              </ul>
              <li>Hormonal methods</li>
              <ul>
                <li>OCP (COC, POCP)</li>
                <li>Hormone bearing / containing IUDs</li>
                <li>Injectables</li>
                <li>Implants</li>
                <li>Contraceptive Skin patches</li>
                <li>Vaginal rings</li>
              </ul>
              <li>Intrauterine devices</li>
              <ul>
                <li>Inert forms</li>
                <li>Copper bearing</li>
                <li>Hormone bearing</li>
              </ul>
              <li>Barrier methods</li>
              <ul>
                <li>Male condom</li>
                <li>Spermicides</li>
                <li>Female condom</li>
              </ul>
              <li>Male Contraception</li>
              <ul>
                <li>Vasectomy (no scalpel)</li>
                <li>Injectable</li>
                <li>Male Pill</li>
                <li>Vaccines</li>
              </ul>
              <li>Permanent methods</li>
              <ul>
                <li>BTL</li>
                <li>Quinacrine</li>
                <li>Essure</li>
              </ul>
              <li>Emergency Contraception</li>
              <ul>
                <li>OCPs, IUD</li>
                <li>Mifepristone (RU-486)</li>
              </ul>

            </ol>
          <section id='heading-2-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-1'>Coitus interruptus</a>
              </h3>
            </header>
            <div class='body'>
               <p>Coitus interruptus involves withdrawal of the entire penis from the vagina before ejaculation. Fertilization is prevented by lack of contact between spermatozoa and the ovum. </p>
               <p>Efficacy: Effectiveness depends largely on the man's capability to withdraw prior to ejaculation. The failure rate is estimated to be approximately 4% in the first year of perfect use. In typical use, the rate is approximately 19% during the first year of use.</p>

               <p><span class="special-text">Advantages:</span></p>
               <ul>
                <li>Immediate availability</li>
                <li>No devices </li>
                <li>No cost </li>
                <li>No chemical involvement</li>
                <li>Theoretical reduced risk of transmission of sexually transmitted diseases (STDs).</li>
               </ul>


               <p><span class="special-text">Disadvantage</span></p>
               <ul>
                <li>The probability of pregnancy is high with incorrect or inconsistent use. </li>
               </ul>

            </div>
          </section>

          <section id='heading-2-2'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-2'>Lactational Amenorrhea Method (LAM)</a>
              </h3>
            </header>
            <div class='body'>
               <p>Elevated prolactin levels and a reduction of gonadotropin-releasing hormone from the hypothalamus during lactation suppress ovulation. </p>
               <p>This leads to a reduction in luteinizing hormone (LH) release and inhibition of follicular maturation. The duration of this suppression varies and is influenced by the frequency and duration of breastfeeding and the length of time since birth. </p>
               <p>Mothers only need to use breastfeeding to be successful; however, as soon as the first menses occurs, she must begin to use another method of birth control to avoid pregnancy. </p>
               <p>Efficacy: The perfect-use failure rate within the first 6 months is 0.5%. The typical-use failure rate within the first 6 months is 2%.</p>
                <p><span class="special-text"></span></p>

                <p><span class="special-text">Advantages:</span></p>
                <ul>
                  <li>Rapid uterine involution. </li>
                  <li>Menses are suppressed.</li>
                  <li>Immediate use after childbirth.</li>
                  <li>Facilitates postpartum weight loss. </li>
                </ul>

                <p><span class="special-text">Disadvantages: </span></p>
                  <ul>
                    <li>Return to fertility is uncertain. </li>
                    <li>Frequent breastfeeding may be inconvenient. </li>
                  </ul>
            </div>
          </section>

          <section id='heading-2-3'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-3'>Natural contraception/family planning</a>
              </h3>
            </header>
            <div class='body'>
               <p>Natural family planning: is one of the most widely used methods of fertility regulation, particularly for those whose religious or cultural beliefs do not permit devices or drugs for contraception. </p>
               <p>This method involves periodic abstinence, with couples attempting to avoid intercourse during a woman's fertile period—around the time of ovulation. Techniques to determine the fertile period include </p>

               <section id='heading-2-3-1'>
                <header>
                  <h4>
                    <a aria-hidden href='#heading-2-3-1'>Periodic abstinence/rhythm method</a>
                  </h4>
                </header>
                <div class='body'>
                    <p>Long and chequered history</p>
                    <p>Fertile period 2-3 days after ovulation. 2 days before no less than 2 days after</p>
                    <p>Promoted by Catholics	</p>
                    <p>Types of periodic abstinence</p>
                    <ul>
                      <li>Calendar method</li>
                      <li>Combined temperature/calendar method</li>
                      <li>Cervical mucus (Billings) method</li>
                      <li>Symptothermal method</li>
                    </ul>

                    <p><span class="special-text">Natural Family Planning (NFP) & Fertility Awareness-Based Methods (FAM)</span></p>
                    <p>Use of physical signs, symptoms, and cycle data to determine when ovulation occurs.</p>
                    <p>Spouses abstain from intercourse during the at-risk fertile days.</p>
                    <p>Or use other methods to avoid pregnancy</p>
                    <ul>
                      <li>Condom, Emergency Contraception</li>
                    </ul>

                    <p><span class="special-text">Effectiveness of NFP (FAM, LAM, SDM, OPD)</span></p>
                    <p>The success of the Natural Family Planning methods depends on:</p>
                    <ul>
                      <li>The accuracy of the method in identifying the woman’s actual fertile days</li>
                      <li>Couples’ ability to correctly identify the fertile time</li>
                      <li>Couple’s ability to follow the rules of the method they are using</li>
                    </ul>
                    <p>Efficacy: The failure rate in typical use is estimated to be approximately 25%. </p>

                    <p><span class="special-text">Advantages </span></p>
                    <ul>
                      <li>No hormone or side effects </li>
                      <li>Acceptable for cultural and religious reasons</li>
                      <li>Immediate return of fertility</li>
                    </ul>
                    <p><span class="special-text">Disadvantages </span></p>
                    <ul>
                      <li>Most suitable – regular and predictable cycles</li>
                      <li>High level of discipline needed</li>
                      <li>Doesn't protect against STI</li>
                      <li>High failure rate</li>
                    </ul>
                </div>
              </section>

              <section id='heading-2-3-2'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-2-3-2'>Cycle Beads Method </a>
                  </h4>
                </header>
                <div class='body'>
                    <p>Also called a Standard Days Method</p>
                    <p>This is a Natural Family Planning Method</p>
                    <p>It is based on the knowledge that the menstrual cycle is made up of a fertile phase preceded and followed by infertile days</p>
                    <p>Cycle beads has 32 beads, each bead represents a day of the menstrual cycle</p>
                    <p>The red bead represents first day of menstruation and of the cycle</p>
                    <p>White beads represent days when a woman can get pregnant</p>
                    <p>95% effective with perfect use!</p>

                    <figure>
                      <img src="/figures/coc (1).jpg" alt="">
                      <figcaption> Fig. Cycle beads</figcaption>
                     </figure>
                    
                </div>
              </section>
            </div>
          </section>

          <section id='heading-2-4'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-4'>Hormonal contraceptives</a>
              </h3>
            </header>
            <div class='body'>
               <p><span class="special-text">Mechanism of Action of Hormonal Contraceptives:</span></p>
               <ul>
                <li>Suppress ovulation (90 to 95% of time)</li>
                <li>Causes thickening of cervical mucus, which impedes sperm penetration and entry into the upper reproductive tract</li>
                <li>Causes endometrial atrophy</li>
                <li>May slow down tubal </li>
               </ul>

               <section id='heading-2-4-1'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-2-4-1'> The Oral Contraceptive Pill</a>
                  </h4>
                </header>
                <div class='body'>
                    <p>Today's users receive a little hormone in each tablet compared with in the 1960s</p>
                    <p>Combined and Progestin-only</p>
                    <p>They can be counted as new methods</p>
                    <p>This reduction has greatly reduced or even eliminated cardiovascular risks</p>
                  
                    <p><span class="special-text">Chewable Oral Contraceptives</span></p>
                    <p>First chewable OCP, Ovcon 35 (Bristol Myers Squibb Company, Princeton, NJ), a spearmint-flavored, 28-day regimen pill that contains the same hormones used in standard OCPs.</p>
                    <p>Women who chew the pills instead of swallowing them should drink 8 oz of liquid afterward to ensure that the full dose reaches the stomach.</p>
                </div>
              </section>

              <section id='heading-2-4-2'>
                <header>
                  <h4>
                    <a aria-hidden href='#heading-2-4-2'>Injectables</a>
                  </h4>
                </header>
                <div class='body'>
                    <p>More and more women are using injectable</p>
                    <ul>
                      <li>Effectiveness</li>
                      <li>Long acting </li>
                      <li>Privacy guaranteed</li>
                    </ul>
                    <p>Types: Progestin-Only</p>
                    <ul>
                      <li>Depo Medroxy Progesterone Acetate (DMPA) 150 mg</li>
                      <ul>
                        <li>Microcrystalline suspension</li>
                        <li>3 monthly</li>
                      </ul>
                      <li>Norethisterone Enanthate (Net-En) 200 mg</li>
                      <ul>
                        <li>In oil</li>
                        <li>2 monthly</li>
                      </ul>
                    </ul>
                    
                    <p><span class="special-text">Newly approved Depo-provera:</span></p>
                    <p>Depo-subQ Provera (DMPA-SC)</p>
                    <ul>
                      <li>Contains 104 mg Depo-medroxy progesterone acetate</li>
                      <li>In micro-crystalline suspension form</li>
                      <li>Now Subcutaneous CF Intramuscular DMPA</li>
                      <li>Also every 12 weeks</li>
                      <li>Should not be used continuously for ˃2 years</li>
                    </ul>

                    <p><span class="special-text"></span></p>
                    <p>Types:</p>
                    <ul>
                      <li>MPA combined with estradiol cypionate (E2C)</li>
                      <ul>
                        <li>Cyclofem, Lunelle (25mg MPA and 5 mg E2C)</li>
                      </ul>
                      <li>Net-En combined with estradiol valerate (E2V)</li>
                      <ul>
                        <li>Mesigyna, Norigynon 50mg Net-En; 5mg E2V</li>
                      </ul>
                    </ul>

                    <p><span class="special-text">NORIGYNON:</span></p>
                    <p>Norigynon is a combined injectable contraceptive that contains 5 mg Estradiol valerate + 50 mg norethisterone enantate.</p>
                    <figure>
                      <img src="/figures/coc (2).jpg" alt="">
                      <figcaption> Fig. Norigynon</figcaption>
                    </figure>

                    <p><i>Mechanisms of Action:</i></p>
                    <ul>
                      <li>Suppresses ovulation</li>
                      <li>Changes endometrium making implantation less likely</li>
                      <li>Thickens cervical mucus preventing sperm penetration </li>
                      <li>Reduces sperm transport in upper genital tract (fallopian tubes)</li>
                    </ul>

                    <figure>
                      <img src="/figures/coc (2).png" alt="">
                      <figcaption>Fig. Mechanism of action </figcaption>
                    </figure>

                    <p><i>Norigynon Injection Schedule</i></p>
                    <ul>
                      <li>Monthly Administration</li>
                      <li>Can be up to 3 days early or late</li>
                      <li>Client can keep appointment card for next injection</li>
                    </ul>

                    <p><i>Effectiveness of Norigynon</i></p>
                    <ul>
                      <li>In clinical trials, Norigynon has proved to be a highly effective contraceptive </li>
                      <li>12-month failure rates are less than 0.4% (1/250) </li>
                    </ul>

                    <p><i>Advantages</i></p>
                    <ul>
                      <li>Highly effective </li>
                      <li>Better cycle control </li>
                      <li>Optimal compliance </li>
                      <li>Reversible </li>
                      <li>Ensures privacy</li>
                      <li>Excellent tolerance (natural Estradiol)</li>
                      <li>Reassuring to women</li>
                      <li>Regular contact with health services</li>
                      <li>Rapid return to fertility</li>
                    </ul>

                    <p><i>Disadvantages </i></p>
                    <ul>
                      <li>Irregular bleeding, amenorrhea, heavy bleeding, prolonged bleeding, headaches, dizziness, body weight & mood changes.</li>
                      <li>Require more frequent injections than POIs.</li>
                      <li>Does not protect against STIs, including HIV.</li>
                    </ul>

                    <p><i>Non-contraceptive Benefits</i></p>
                    <ul>
                      <li>Decreases menstrual flow (lighter, shorter periods)</li>
                      <li>Decreases menstrual cramps (dysmenorrhoea)</li>
                      <li>May improve anemia</li>
                      <li>Favorable metabolic profile (lipid, carbohydrate, liver)</li>
                      <li>Protects against ovarian and endometrial cancer</li>
                      <li>Decreases benign breast disease and ovarian cysts</li>
                      <li>Prevents ectopic pregnancy</li>
                      <li>Protects against some causes of PID</li>
                    </ul>

                    <p><i>Combined Injectables: Safety</i></p>

                    <ul>
                      <li>Safety of progestins is well established.</li>
                      <li>Daily dose of estrogen is small.</li>
                      <li>Long-term safety information not yet available.</li>
                      <li>Contraindications based on those for COCs.</li>
                    </ul>

                    <p><i>Norigynon: user profile</i></p>
                    <ul>
                      <li>Women demanding a “normal menstrual” bleeding pattern (less bleeding irregularities, less amenorrhea) and high contraceptive efficacy.</li>
                    </ul>
                    <p><i>Eligibility Criteria: who can use:</i></p>
                    <p>Until sufficient clinical data become available, the eligibility criteria for the use of combined injectable contraceptives are based on data from combined oral contraceptives.</p>
                    <ul>
                      <li>Women who want a highly effective easy to use method</li>
                      <li>Women wanting a reversible method</li>
                      <li>Women of any age and any parity including adolescents</li>
                      <li>Women who want discretion</li>
                      <li>Women with sickle cell disease</li>
                      <li>Women who can’t tolerate other methods</li>
                      <li>Women who:</li>
                      <ul>
                        <li>Are of any reproductive age or parity who want highly effective protection against pregnancy</li>
                        <li>Are breast feeding (6 months or more postpartum) or when supplementation of infants’ diet begins (if before 6 months)</li>
                        <li>Are postpartum and not breast feeding (may begin after third week postpartum)</li>
                        <li>Are post abortion clients (may begin immediately)</li>
                        <li>Cannot remember to take a pill everyday</li>
                      </ul>
                    </ul>
                    <li>Women with:</li>
                    <ul>
                      <li>Anemia</li>
                      <li>Severe menstrual cramping (dysmenorrhoea)</li>
                      <li>Irregular menstrual cycles</li>
                      <li>Histories of ectopic pregnancy</li>
                    </ul>

                    <p><i>Who Should Not Use Norigynon (WHO Class 4):</i></p>
                    <p>Norigynon should not be used if a woman:</p>
                    <ul>
                      <li>Is pregnant (known or suspected)</li>
                      <li>Is breast feeding (< 6 months postpartum)</li>
                      <li>Has ischemic heart disease or stroke (current or history of)</li>
                      <li>Has blood clotting disorders (deep vein thrombophlebitis or pulmonary embolism</li>
                      <li>Is a smoker and age 35 years or older</li>
                      <li>Has diabetes (> 20 years duration)</li>
                      <li>Has headaches (migraine)</li>
                      <li>Has high blood pressure (> 180/110)</li>
                      <li>Has breast cancer</li>
                      <li>Has liver tumors</li>
                      <li>Has to undergo major surgery with prolonged bed rest</li>
                    </ul>

                    <p><span class="special-text">When to begin Combined Injectables</span></p>
                    <ul>
                      <li>Any time during menstrual cycle</li>
                      <li>Backup recommended if given after day 7</li>
                      <li>Postpartum:</li>
                      <ul>
                        <li>Not breastfeeding: delay 3 weeks</li>
                        <li>Breastfeeding: delay of 6 months recommended</li>
                      </ul>
                      <li>Post-abortion: immediately</li>
                    </ul>

                    <p><span class="special-text">Counseling</span></p>
                    <p>Clients considering the use of injectable contraception should be clearly informed about the advantages and disadvantages of the agents, their side-effects, their cost, and the alternative contraceptive options. </p>
                    <p>Where once-a-month injectables are available, clients should be told about the differences between these injectables and POIs.</p>
                    <p>Women who desire a rapid return to fertility on discontinuation of their contraceptive should be advised to use CICs where available or another method.</p>

                    <p><span class="special-text"></span></p>
                    <p>Addition of small quantities of testosterone to injectable to:</p>
                    <ul>
                      <li>Correct risk of osteoporosis from long term use!</li>
                      <li>Improve or correct risk of reduced libido </li>
                    </ul>
                
                </div>
              </section>

              <section id='heading-2-4-3'>
                <header>
                  <h4>
                    <a aria-hidden href='#heading-2-4-3'> Contraceptive Implants</a>
                   </h4>
                </header>
                <div class='body'>
                  <p>All can be considered as new (1985)</p>
                  <p>Implanted into medial aspect of less dominant arm</p>
                  <p>Initially Six Rods, Norplant (now discarded)</p>
                  <ul>
                    <li>Inserted last ones in 2005 in Jos</li>
                  </ul>
                  <p>Two rod Jadelle (levonorgestrel) – 5 years</p>
                  <p>One rod Implanon (etonogestrel) – 3 years</p>
                  <p>Bio-degradable (Capronor) that does not require removal (2 years) – Developed by Research Triangle Institute.</p>
               

                <p><span class="special-text">NEXPLANON:</span></p>
                <p>Nexplanon is essentially identical to Implanon except Nexplanon has 15 mg of Barium sulphate added to the core, so it is detectable by x-ray.1</p>
                <p>Nexplanon also has a pre-loaded applicator for easier insertion</p>
                <p>Nexplanon is off-white, non-biodegradable and 4 cm long, diameter of 2 mm</p>
                <ul>
                  <li>2 mm wide</li>
                  <li>4 cm long</li>
                </ul>

                <figure>
                  <img src="/figures/coc (9).png" alt="">
                  <figcaption>Fig. Norplant Implants </figcaption>
                </figure>

                <figure>
                  <img src="/figures/coc (10).png" alt="">
                  <figcaption> Fig. Jadelle Implants</figcaption>
                </figure>

                <figure>
                  <img src="/figures//coc (12).png" alt="">
                  <figcaption>Fig. Jadelle Implants (2 capsules) </figcaption>
                </figure>

                <figure>
                  <img src="/figures/coc (13).png" alt="">
                  <figcaption>Fig. Implanon Implant  </figcaption>
                </figure>

                <figure>
                  <img src="/figures/coc (14).png" alt="">
                  <figcaption> Fig. Nexplanon</figcaption>
                </figure>
              
        
                </div>
              </section>

              <section id='heading-2-4-4'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-2-4-4'>Vaginal contraceptive rings</a>
                    <p></p>
                    <p></p>
                  </h4>
                </header>
                <div class='body'>
                    <p>Method of long-term contraception which is entirely patient’s control.</p>
                    <p>Steroids absorbed efficiently through vaginal epithelium.</p>
                  
                    <p><span class="special-text">Advantages</span></p>
                    <ul>
                      <li>Under patient’s control</li>
                      <li>Not coitus related</li>
                      <li>No daily administration</li>
                      <li>Greater contraceptive effect</li>
                      <li>Milder adverse effects.</li>
                    </ul>

                    <p>Design of vaginal contraceptive rings</p>
                    <ul>
                      <li>Vaginal fornix around cervix</li>
                      <ul>
                        <li>Homogenous ring</li>
                        <li>Shell ring</li>
                        <li>Core ring</li>
                      </ul>
                    </ul>

                    <figure>
                      <img src="/figures/coc (4).png" alt="">
                      <figcaption>Fig. Vaginal Ring (PVR) (Progesterone-Only)</figcaption>
                    </figure>

                    <p>One of the newest developments in hormonal contraceptives is the vaginal contraceptive ring.</p>
                    <p>Also known as the Ring and sold under the brand name NuvaRing.</p>
                    <p>Each ring provides continuous protection against pregnancy for up to one month.</p>

                    <p><span class="special-text">How the Ring is used</span></p>
                    <p>A new vaginal ring needs to be inserted every month. </p>
                    <p>Once inserted, the Ring is worn for 3 consecutive weeks before it is removed for 1 week. </p>
                    <p>During the week that the Ring is not worn, menstruation occurs.</p>
                    <p>Each ring provides a month’s contraception</p>

                    <figure>
                      <img src="/figures/coc (5).png" alt="">
                      <figcaption>Fig. Progesterone Vaginal Ring (PVR) (Progesterone-Only)</figcaption>
                    </figure>

                    <p><span class="special-text">Progesterone Vaginal Ring</span></p>
                    <p>Progesterone diffuses at a continuous flow of 10mg per day through the silicone</p>
                    <ul>
                      <li>Prolongs lactation amenorrhea</li>
                      <li>Used for Postpartum contraception</li>
                      <li>After 6 weeks of delivery and for 3 months</li>
                    </ul>
                    <p>A vaginal ring is inserted at postnatal visit (6 weeks)</p>
                    <p>Once inserted, the Ring is worn for 3 months </p>
                    <p>At end of 3 months, it is removed and another replaced</p>
                    <p>For now, use is stopped when menstruation returns, or for a maximum of 1 year</p>
                    <p>Meant for breastfeeding women only</p>


                </div>
              </section>

              <section id='heading-2-4-5'>
                <header>
                  <h4>
        
                    <a aria-hidden href='#heading-2-4-5'>Contraceptive Patch</a>
                  </h4>
                </header>
                <div class='body'>
                  <figure>
                    <img src="/figures/coc (7).png" alt="">
                    <figcaption> Fig. The Contraceptive Patch</figcaption>
                 </figure>
                 <p>Trans-dermal contraceptive system</p>
                 <p>Square, flexible, extended-release matrix patch system</p>
                 <p>Contains norelgestromin (NGMN) and ethinyl estradiol (EE) for use in a weekly dosing schedule</p>
                 <p>Product launched: April 2002</p>


                 <p><span class="special-text">Benefits of the Patch</span></p>
                 <ul>
                  <li>Female-controlled</li>
                  <li>Prompt contraceptive reversibility</li>
                  <li>Allows for spontaneity</li>
                  <li>Highly efficacious contraceptive</li>
                  <li>High rates of compliance across age groups</li>
                 </ul>

                 <p><span class="special-text">Method of use</span></p>
                 <p>A woman applies her first patch onto her</p>
                 <ul>
                  <li>Upper outer arm		</li>
                  <li>Abdomen</li>
                  <li>Buttocks</li>
                  <li>Thigh</li>
                 </ul>
                 <p>Applied weekly</p>
                 <p>The day of application is known from that point as patch change day. </p>
                 <p>On the 4th patch change day, the patch is removed and not replaced.</p>
                 <p>The woman waits 7 days without a patch in place, and on the next patch change day she applies a new patch (a new cycle)</p>
                </div>
              </section>
            </div>
          </section>

          <section id='heading-2-5'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-5'>Intrauterine Devices</a>
              </h3>
            </header>
            <div class='body'>
               <p>Lippes Loop as a contraceptive now obsolete</p>
               <ul>
                <li>May be found in Gynecology theatres for treatment of Ashermans</li>
               </ul>
               <p>CuT380A: Commonest IUD in use today</p>
               <p>New IUD designs may reduce side effects </p>
               <ul>
                <li>Cramping</li>
                <li>Excessive menstrual loss</li>
               </ul>
               <p>1970s: 	The second generation of plastic- copper IUDs came around. These IUDs increased the surface area of the devices and increased their effectiveness to above 99%. </p>

               <p><span class="special-text">Hormone Containing IUDs</span></p>
               <p>Progestasert: Contains pure Progesterone</p>
               <ul>
                <li>Meant for 1 year</li>
                <li>Not easily available</li>
               </ul>

               <p>Levonova: levonorgestrel IUD (Mirena/Eliora)</p>
               <ul>
                <li>May actually reduce menstrual loss</li>
                <li>Lasts for 5 and up to 7 years</li>
               </ul>
            </div>
          </section>

          <section id='heading-2-6'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-6'>Barrier devices and chemical agents</a>
              </h3>
            </header>
            <div class='body'>
               <p><span class="special-text">Cap</span></p>
               <ul>
                <li>Vaginal diaphragms most widely used spermicide types coil springs, flat spring, arcing? Failure rate 2-20 pregnancies per 100 women users per year of exposure.</li>
                <li>Cervical Cap</li>
                <li>Fem-cap</li>
                <li>Lea’s shield</li>
                <li>Long acting spermicides releasing diaphragms</li>
                <li>PH sensitive releasing </li>
               </ul>
               <p><span class="special-text">Female condom, panty condom</span></p>
               <ul>
                <li>Pouch thin polyurethane with 2 flexible	rings at each end- one deep and the other at the intriotus)</li>
                <li>Failure rate - 26% for the first year</li>
                <li>Overall acceptability 65-79% for women users and 75-80% for their partners.</li>
               </ul>

               <p><span class="special-text">Sponge</span></p>
               <ul>
                <li>Contains polyurethane and Nonoxynol-9</li>
                <ul>
                  <li>Toxic to Spermatozoa</li>
                 </ul>
               </ul>

               <p><span class="special-text">Chemical agents</span></p>
               <ul>
                <li>Foams, jellies, tablets, suppositories, aerosols</li>
                <li>Nonoxynol-9, Octoxynol-9, Menfegol</li>
               </ul>

               <p><span class="special-text">Panty Condom</span></p>
               <ul>
                <li>A condom for women, used in the traditional sense as a barrier birth control method</li>
                <li>Protects against STIs and HIV; Prevents unwanted pregnancy (Dual Protection)</li>
                <li>Created to empower women with a contraceptive under their control</li>
                <li>Discreet, Sexy, sensual, safe, easy to use</li>
                <li>Can be worn all day</li>
                <li>The condom itself is protected inside a membrane until used</li>
                <li>The panty is re-usable the condom is replaceable</li>
                <li>Manufactured from polyethylene</li>
                <li>Not Available here yet!</li>
               </ul>
              <figure>
               <img src="/figures/coc (15).png" alt="">
               <figcaption> Fig. Panty condom</figcaption>
              </figure>
            </div>
          </section>

          <section id='heading-2-7'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-7'>Male Contraception</a>
              </h3>
            </header>
            <div class='body'>
               <p>Abstinence</p>
               <p>Withdrawal Method or ‘Coitus Interruptus’</p>
               <p>Condoms</p>
               <p>Vasectomy</p>
               <ul>
                <li>Traditional or scalpel method</li>
                <li>No scalpel method</li>
               </ul>
               <p>Male Pill</p>
               <p>Vas deferens plugs</p>
               <p>Immunization? </p>

               <p><span class="special-text">Male Condom</span></p>
               <p>1864 - Gabriel Fallopio, Linen Sheath</p>
               <p>20% of contraceptives use; renewed interest - Aids pandemic.</p>
               <ul>
                <li>Latex</li>
                <ul>
                  <li>Teat ended</li>
                  <li>Plain</li>
                 </ul>
                <li>Non-latex - polyurethane, plastics stronger, less rupture</li>
                <ul>
                  <li>Failure rate: 3 per 100 woman years</li>
                  <li>High risk women - “Double Dutch” method</li>
                 </ul>
               </ul>

               <p><span class="special-text">The Male Pill!</span></p>
               <p>Gossypol, a derivative of cotton seed oil </p>
               <ul>
                <li>Demonstrated to depress spermatogenesis</li>
                <li>Effecttiveness rate of 99%</li>
                <li>Potassium depletion has been reported in some users and this may lead to cardiac arrhythmias</li>
               </ul>
               <p>Testosterone Derivative e.g. Testosterone enanthate (may interfere with erection) </p>
               <p>TE + LHRH Agonist: - which effectively depresses spermatogenesis, may preserve libido</p>
               <p>Testosterone + Progestin: being tried as male contraceptive</p>

               <p><span class="special-text">The ‘Male Injectable’</span></p>
               <p>Male systemic method using testosterone</p>
               <ul>
                <li>Suppresses/inhibits pituitary gonadotropins.</li>
                <li>Testosterone levels are still adequate for male behavior.</li>
               </ul>
               <p>Levels in testis fall so low that sperm production stops.</p>
               <p>High doses of testosterone in the man can cause aggressive male behavior.</p>
               <p>Sperm production takes 120 days, so male systemic methods may take long time to act and to reverse.</p>
               <p>No natural period of inhibition of fertility to imitate in the man as in the female (during pregnancy and lactation).</p>
            </div>
          </section>

          <section id='heading-2-8'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-8'>Permanent methods of Contraception</a>
              </h3>
            </header>
            <div class='body'>
               <p>Considered irreversible</p>
               <p> Male:</p>
               <ul>
                <li>Easier</li>
                <li>Cheaper</li>
                <li>Complications less</li>
               </ul>

               <p>Female:</p>
               <ul>
                <li>More costly</li>
                <li>More technical</li>
                <li>More complications</li>
               </ul>

               <p><span class="special-text">Male Permanent Methods</span></p>
               <p>Vasectomy</p>
               <p>No-Scalpel Vasectomy</p>
               <p>Vas deferens plugs</p>

               <p><span class="special-text">Female Permanent Methods</span></p>
               <p>Bilateral Tubal Ligation</p>
               <ul>
                <li>Laparotomy</li>
                <li>Laparoscopy </li>
                <li>Clips, Yoon Rings</li>
                <li>Minilaparotomy under local anesthesia</li>
                <li>Quinacrine </li>
                <li>Essure</li>
               </ul>

               <p><span class="special-text">Tubal ligation techniques</span></p>
               <ol type="a">
                  <li>Pomeroy</li>
                  <li>Madlener</li>
                  <li>Fimbriectomy</li>
                  <li>Salpingectomy</li>
                  <li>Uchinda</li>
                  <li>Irvine</li>
               </ol>
               <p>E and F more effective</p>
               <p>Others?</p>
               <ul>
                <li>Occlusive bands or rings: Falope</li>
                <li>Occlusive clips - Filshie or Hulka - Clemems</li>
                <li>Tubal diathermy (Thermocoagulation)</li>
                <li>Hysterectomy</li>
               </ul>

               <p><span class="special-text"></span></p>
               <ul>
                <li>Immediate</li>
                <li>Delayed</li>
                <li>Long term</li>
               </ul>

               <p><span class="special-text">Quinacrine</span></p>
               <p>A chemical compound in form of pellets</p>
               <p>Results in permanent sterilization when inserted into the uterus - tubes</p>
               <p>Causes scaring which blocks the fallopian tubes. </p>

               <p><i>The Adiana Procedure: Quinacrine</i></p>
               <ul>
                <li>Catheter is inserted through a hysteroscope into the fallopian tube  </li>
                <li>A superficial lesion is created by low level radiofrequency energy </li>
                <li>A porous plastic implant called matrix is placed into the lesion</li>
                <li>The surrounding tissues grows into the matrix over the next 12 weeks  </li>
                <li>The grown tissues result in total closure of the fallopian tubes.</li>
               </ul>

               <p><span class="special-text">Essure </span></p>
               <figure>
                <img src="/figures/coc (3).png" alt="">
                <figcaption>Fig. Essure Micro-Insert </figcaption>
               </figure>

               <p>Non-surgical sterilization that uses the trans-cervical route.</p>
               <p>Consist of a micro-coil made up of a spring-like device  </p>
               <p>The coil is placed in the uterine end of the fallopian tube using a hysteroscope  </p>
               <p>Scar tissues grow into the coil to plug it within 3 months </p>
               <p>There is need for a temporary contraceptive method in the first   three months.</p>
               <p>Tubal blockage is confirmed after 3 months with ultrasound or Fluoroscopy or HSG.  </p>
            </div>
          </section>

          <section id='heading-2-9'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-9'>Emergency contraception</a>
              </h3>
            </header>
            <div class='body'>
               <p>Yuzpe Regimen</p>
               <ul>
                <li>High Dose Combined Pills</li>
                <li>Low Dose Combined Pills</li>
               </ul>
               <p>Progestin Only (High Dose)</p>
               <ul>
                <li>Postinor</li>
                <li>Provera</li>
               </ul>
               <p>IUD: Inserted within 5 days of Coitus</p>
               <p>Mifepristone (RU 486)</p>

               <p><span class="special-text">Mechanism of Action of OCPs in Emergency Contraception</span></p>
               <ul>
                <li>If taken before ovulation, ECPs disrupt normal follicular development and maturation,</li>
                <li>Block LH surge, and inhibit ovulation,</li>
                <li>May also create deficient luteal phase,</li>
                <li>May affect tubal transport of sperm or ova</li>
               </ul>

               <p><span class="special-text">Mechanism of Action of IUD  in Emergency Contraception</span></p>
               <ul>
                <li>IUD in EC</li>
                <li>Largely unknown</li>
                <li>Causes endometrial changes that inhibit ovulation</li>
                <li>Copper ions released appear to be directly embryotoxic </li>
                <li>Rarely, may act as contraceptive, if inserted days before ovulation</li>
               </ul>

               <p><span class="special-text">Emergency Contraception with Mifepristone (RU-486)</span></p>
               <ul>
                <li>An anti-progestogen</li>
                <li>Single dose of 10mg to 25mg (China) mifepristone (RU-486) </li>
                <li>Taken within 5 days of unprotected intercourse. </li>
                <li>Effectiveness: Prevents over 98% of pregnancies</li>
               </ul>

               <p><i>Mechanism of Action of Mifepristone</i></p>
               <ul>
                <li>Blocks action of progesterone by binding to its receptors</li>
                <li>Stops ovulation if given in follicular phase (contraceptive)</li>
                <li>Slows endometrial maturation in luteal phase (interceptive)</li>
                <li>New Developments in Contraception</li>
                <li>Contraceptive vaccine</li>
                <li>Theoretically possible</li>
                <li>Complexity of the topic and lack of funds have stalled research</li>
               </ul>

               
            </div>
          </section>

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Constraints for Contraceptive Development</a>
          </h2>
        </header>
        <div class='body'>
          <p>Insufficient Funds for new contraceptive methods development to bring about any real revolution in family planning</p>
          <p>For now, best option is the slow but steady improvement in current methods</p>
          <p>May be some new barrier methods that could offer protection against HIV and other STIs</p>

          <blockquote>
           “When individuals of any social, ethnic, religious, or cultural background are given genuine choices, then the overwhelming majority does not choose to have more children than their love and physical resources can support”	
           <p>(Senanaye P and Potts M, 2008) </p>
          </blockquote>

          <p><span class="special-text">Conclusion </span></p>
          <p>Contraceptives have evolved over time offering prospective users variety to choose from.</p>
          <p>Clients that find one method uncomfortable can switch over to another.</p>
          <p>A plethora of methods offers better choices.</p>
          <p>Contraceptive development is long, slow, expensive and uncertain process.</p>
          <p>But not all hope is lost.</p>
          <p>You guys are a sure hope for the future of contraception.</p>
        </div>

      </section>

      <div class="contact">
        <hr style="margin: 3rem 0;">

        <!-- <p>Send us a <a href="mailto:obgyn.materia@gmail.com"><span class="special-text-2">mail</span></a> at 
         <br> obgyn.materia@gmail.com.</p>
        <p>Or send your comments, corrections, explanations/clarifications and requests/suggestions to our 
         <br> <a href="" class="special-text-2" style="text-decoration: none;">WhatsApp group</a>.</p> -->
      </div>
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p>obgyn.materia.[beta]</p>    
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="/main.js"></script>
</body>
</html>
 
